# Infectious Disease Modeling in Saudi Arabia

## Problem

At the start of the COVID-19 pandemic, many countries made different decisions regarding policies towards this new coronavirus. Some of these decisions were risky, but all of them impacted their countries in many different sectors, including the political and economic. Quick responses were vital to control the spread of the disease.

Lean Business Services is a leading company in assisting and developing the health sector in Saudi Arabia. During COVID-19, simulation was needed to help understand different policies the government introduced and the impact of those policies on controlling the spread of COVID-19.

This simulation could help in capacity planning for health resources, which at the height of the pandemic were limited. Lean, therefore, built a simulation model using AnyLogic software to understand the spread of the disease and to identify how different policies could change the spread of the virus over time.

## Solution

A SEIR(D) model is a mathematical model of the spread of an infectious disease. In a population, every individual exists in one of five states:

• Susceptible (S) to the disease.
• Exposed (E) to the disease.
• Infected (I) by the disease.
• Recovered (R) from the disease.
• Died (D) from the disease.

There is also immunization to consider. This is further split into multiple models as immunity fades away and if immunization is not as effective for all people.

Lean built this core SEIR(D) model using system dynamics. Then they built many other models on top of it. The models they produced were multimethod models between agent-based and system dynamics. The agent-based part of the model simulated the behavior on the individual level in depth, while the system dynamics part handled large amounts of information on the aggregate level. Combining these two increased the model flexibility to simulate various scenarios without delay.

A multimethod model has 82 unique parameters and 20 health directorates or divisions. For each directorate there is a separate simulation model. Therefore, in total there are 1640 parameters, which are divided into 4 main categories:

1. Healthcare resources.
2. Disease behavior specifically related to COVID-19.
3. Population behavior.
4. Demographics.

From these unique parameters, there are 95 distinctive pathways again multiplied by the 20 directorates creating 1900 dynamic events. Pathways in this case are events, and these can be based on if statements, for example, the number of ventilators available. If there are no more available ventilators, then anyone who needs one would not have access and this could lead to death and an increase in the death rate.

Events and assumptions in the model included international travel, work, Eid – which is a national holiday in Saudi Arabia, the program scenarios, vaccination, and school. Additionally, capacity planning was built into the model and included such resources as nurses, ICU beds, doctors, and so on.

The model interface is very user-friendly, giving users the possibility to change the parameters, policies, and importantly, even the population. As a result, the model can be applied to other countries.

There were also just agent-based models designed for specific simulations such as in an airplane. Here, there is clear and specific behavior for each agent, or passenger. On an airplane, for example, two people can sit next to each other and if one is infectious, then the other could be susceptible. As a result, the chance of spreading the disease is higher than if those people were not sitting next to each other.

Notably, Lean built a separate agent-based model for the Hajj, the annual Islamic pilgrimage to Mecca, Saudi Arabia. Different policies or precautions were taken to understand the impact of each, for example, taking 2 swabs instead of 1 swab before the Hajj, or if there would be isolation for people at home or at Makkah.

## Results

After running the models, Lean could provide detailed reports, including the forecasted numbers of cases for the next week or next month, the predicted outcome of schools returning to face-to-face learning, the mortality rate due to COVID-19, the impact of the Hajj, and so on.

The case study was presented by Ahmed Alhomaid, of Lean Business Services, at the AnyLogic Conference 2021.

The slides are available as a PDF.

## Ähnliche Fallstudien

• ### Entscheidungsunterstützung im Healthcare-Bereich durch hybride Simulationsmethoden – Mobile Stroke Units

Schlaganfall ist eine der wichtigsten Ursachen für Behinderung von Menschen und verursacht hohe Pflege- und Rehakosten. Aufgrund einer alternden Bevölkerung ist in der Zukunft außerdem mit einer steigenden Inzidenz zu rechen. Patienten verlieren viel Zeit beim Transport in das Krankenhaus und in internen...

• ### Manufacturing Decision Support for New Pharma Facility

GSK determined a possible 20% lower capital expenditure for the renewal of its biopharmaceutical manufacturing facility in Parma, Italy, by using simulation modeling. For analysis, planning, and decision support on the project, GSK worked with the award-winning tech application company Decision Lab.

• ### Modellierung für pharmazeutische Distributionslager

Cardinal Health, ein Milliarden-Dollar schwerer Arzneimittelvertrieb und Logistikunternehmen, vertreibt mehrere Produkte, von markengeschützten Arzneimitteln und Generika zu frei verkäuflichen Arzneimitteln, Artikel für Gesundheits - und Schönheitspflege und die eigene Hausmarke. Sie sind mit einer Vielzahl der typischen...

• ### Verwendung von prädiktiver Modellierung im Gesundheitswesen zur Simulation klinischer Studien

Periphere Neuropathie ist eine Krankheit, die durch chronisch hohen Blutzucker und Diabetes verursacht wird. Sie führt zu Schwäche, Taubheit und Schmerzen in Händen, Füßen und anderen Körperteilen. Etwa 60% aller Menschen mit Diabetes erkranken daran. Um nachhaltige Behandlungsentscheidungen zu treffen und personalisierte...

• ### Lieferkettenplanung für einen Impfstoffhersteller mit Simulationssoftware

GlaxoSmithKline (GSK) war 2014 das sechstgrößte Pharmaunternehmen der Welt. Das Unternehmen brachte ein neues Impfstoffprodukt auf einen neuen Markt, der ein anderes Vertriebsnetz benötigte. Daher musste das Unternehmen eine neue Lieferkette entwerfen und die Herstellungsprozesse auf sie abstimmen.

• ### Using Production Planning and Scheduling Software in the Cell Therapy Industry

Cell therapy is a fast-growing industry with many unique and complicated manufacturing processes. One stem cell producer wanted to develop the product without expensive and life-endangering delays. To do this, they contracted two consultants to create a digital twin for maximizing clean room utilization and identifying...

• ### Hospital Digital Twin to Improve Operations and Enhance Patient Experience

Decision Lab and the National Health Services in England collaborated on a project of building a hospital digital twin. The tool would help the NHS Foundation Trust understand the processes in two of its hospitals in England, optimize their operations, enhance patient experience, and better allocate resources, such as beds and...

• ### Eine agentenbasierte Erklärung für die Änderung der Lebenssituation der psychisch kranken Bevölkerung

Das Wohnumfeld der dauerhaft psychisch schwer kranken Bevölkerung in den Vereinigten Staaten hat sich über die letzten 60 Jahre stark verändert. Besonders deutlich wird das durch den prozentualen Anteil der Personen, die in Haft leben gegenüber dem prozentualen Anteil der Menschen, die in der Obhut des Gemeinwesens oder...

• ### Verbesserung des Patientenflusses in einer Ambulanz mit Hilfe ereignisorientierter Modellierung

Das Health Arnett Hospital der Indiana Universität, ein Akutkrankenhaus mit Komplettservice und einer ambulanten Klinik mit mehreren Spezialgebieten, sah sich schlechten Statistiken gegenüber, da die Anzahl der No-show-Patienten (diejenigen, die nicht zu ihren geplanten Terminen erscheinen) dramatisch auf 30 % anstieg.

• ### Vorausschauende Modellierung im Gesundheitswesen hilft bei der Effektivitätsbewertung der Behandlung mit einem neuen Medikament

Eine pharmazeutische Firma wollte die Behandlung mit einem neuen Medikament einführen, die Notaufnahmen bei einer Verbesserung der betrieblichen Leistungsfähigkeit in Bezug auf Effizienz und Zeit helfen würde. Um den Effekt ihrer neuen Behandlung auf den Betrieb von Notaufnahmen zu bewerten, beauftragte der Kunde die...